Beclometasone/formoterol/glycopyrronium

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Beclometasone/formoterol/glycopyrronium
Combination of
Beclometasone dipropionateGlucocorticoid
FormoterolLong-acting β2 agonist
Glycopyrronium bromideAntimuscarinic
Clinical data
Trade namesTrimbow
Routes of
administration
Inhalation
ATC code

Beclometasone/formoterol/glycopyrronium (trade name Trimbow) is an inhalable combination drug for the treatment of chronic obstructive pulmonary disease (COPD). In May 2017, the European Committee for Medicinal Products for Human Use recommended granting a marketing authorisation for the drug.[1]

References[edit]

  1. ^ "Summary of opinion for Trimbow" (PDF). European Medicines Agency. 23 May 2017.